Not Yet Recruiting
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
NCT07581951
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
- Locations
-
Not specified